<DOC>
	<DOC>NCT01979926</DOC>
	<brief_summary>The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the Efficacy, Safety and Pharmacokinetics of N02RS1 600mg and 1,200mg per day in Patients With acute and acute exacerbation of chronic bronchitis for 7 days.</brief_summary>
	<brief_title>Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis, Chronic</mesh_term>
	<criteria>Patients over 18, under 75 years of age Patients Acute and Chronic Bronchitis Patients who have gotten a glucocorticoids treatment within 4 weeks. Patients who need treatments of antibiotic and acute bronchitis infection. Patients who have gotten teatments of antibiotic,bronchodilator,painkiller and secretagog within 7 days. Bronchial asthma patient. Patients who have an indication of bleeding. Patients who have a serious heart and renal disease or liver ailment or immunosuppressive response. Patients who have history of over 3 phage of Chronic obstructiv lung disease Bronchiectasis patients.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>